Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Annual Review of Pharmacology and Toxicology|June 3, 2000
The impact of genomics-based technologies on drug safety evaluationJ F Waring, R G Ulrich
The Journal of Biological Chemistry|November 21, 2000
Identification of CCAAT displacement protein (CDP/cut) as a locus-specific repressor of major histocompatibility complex gene expression in human tumor cellsS R Snyder, J Wang, J F Waring, et al.
The Journal of Biological Chemistry|May 19, 1995
The human leukocyte antigen A2 interferon-stimulated response element consensus sequence binds a nuclear factor required for constitutive expressionJ F Waring, J E Radford, L J Burns, et al.
Journal of Interferon Research|April 1, 1993
Stimulation of MHC class I transcription by interferon-gamma involves a non-A, non-C kinase in addition to protein kinase CJ E Radford, J F Waring, J K Pohlman, et al.
Blood|December 10, 1999
Interferon consensus sequence binding protein and interferon regulatory factor-4/Pip form a complex that represses the expression of the interferon-stimulated gene-15 in macrophagesF Rosenbauer, J F Waring, J Foerster, et al.
Toxicology Letters|April 27, 2001
Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicityJ F Waring, R Ciurlionis, R A Jolly, et al.
Blood|March 15, 1993
Only the HLA class I gene minimal promoter elements are required for transactivation by human cytomegalovirus immediate early genesL J Burns, J F Waring, J J Reuter, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 10, 2001
A 3'-transcribed region of the HLA-A2 gene mediates posttranscriptional stimulation by IFN-gammaS R Snyder, J F Waring, S Z Zhu, et al.
Journal of Viral Hepatitis|December 8, 2016
Epigenetic analysis of the IFNλ3 gene identifies a novel marker for response to therapy in HCV-infected subjectsJ F Waring, J W Davis, E Dumas, et al.
Journal of Viral Hepatitis|October 6, 2015
Serum miR-122 may serve as a biomarker for response to direct acting antivirals: effect of paritaprevir/R with dasabuvir or ombitasvir on miR-122 in HCV-infected subjectsJ F Waring, E O Dumas, S Abel, et al.
Pageof 2